(1)
Lack of Placental Transfer of Certolizumab Pegol During Pregnancy: Results from CRIB, a Prospective, Postmarketing, Multicenter, Pharmacokinetic Study. J of Skin 2017, 1 (3.1), s21. https://doi.org/10.25251/skin.1.supp.20.